TELESAT CORP (TSAT) Fundamental Analysis & Valuation

NASDAQ:TSATCA8795123097

Current stock price

40.38 USD
+1.04 (+2.64%)
At close:
40.38 USD
0 (0%)
After Hours:

This TSAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. TSAT Profitability Analysis

1.1 Basic Checks

  • In the past year TSAT has reported negative net income.
  • TSAT had a positive operating cash flow in the past year.
  • In multiple years TSAT reported negative net income over the last 5 years.
  • TSAT had a positive operating cash flow in each of the past 5 years.
TSAT Yearly Net Income VS EBIT VS OCF VS FCFTSAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of TSAT (-2.35%) is comparable to the rest of the industry.
  • TSAT has a Return On Equity of -29.27%. This is in the lower half of the industry: TSAT underperforms 67.57% of its industry peers.
  • With a Return On Invested Capital value of 1.38%, TSAT perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
  • TSAT had an Average Return On Invested Capital over the past 3 years of 2.65%. This is below the industry average of 5.91%.
Industry RankSector Rank
ROA -2.35%
ROE -29.27%
ROIC 1.38%
ROA(3y)-0.37%
ROA(5y)0.03%
ROE(3y)-5.96%
ROE(5y)0.43%
ROIC(3y)2.65%
ROIC(5y)3.11%
TSAT Yearly ROA, ROE, ROICTSAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100

1.3 Margins

  • TSAT has a Operating Margin of 13.71%. This is comparable to the rest of the industry: TSAT outperforms 56.76% of its industry peers.
  • In the last couple of years the Operating Margin of TSAT has declined.
  • TSAT has a Gross Margin of 94.56%. This is amongst the best in the industry. TSAT outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of TSAT has remained more or less at the same level.
Industry RankSector Rank
OM 13.71%
PM (TTM) N/A
GM 94.56%
OM growth 3Y-29.46%
OM growth 5Y-22.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.29%
TSAT Yearly Profit, Operating, Gross MarginsTSAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

0

2. TSAT Health Analysis

2.1 Basic Checks

  • TSAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TSAT has more shares outstanding than it did 1 year ago.
  • TSAT has less shares outstanding than it did 5 years ago.
  • TSAT has a worse debt/assets ratio than last year.
TSAT Yearly Shares OutstandingTSAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TSAT Yearly Total Debt VS Total AssetsTSAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • TSAT has an Altman-Z score of 0.01. This is a bad value and indicates that TSAT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of TSAT (0.01) is worse than 86.49% of its industry peers.
  • A Debt/Equity ratio of 2.17 is on the high side and indicates that TSAT has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.17, TSAT is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACC0.24
WACC5.74%
TSAT Yearly LT Debt VS Equity VS FCFTSAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

2.3 Liquidity

  • TSAT has a Current Ratio of 0.25. This is a bad value and indicates that TSAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of TSAT (0.25) is worse than 97.30% of its industry peers.
  • TSAT has a Quick Ratio of 0.25. This is a bad value and indicates that TSAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • TSAT has a worse Quick ratio (0.25) than 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
TSAT Yearly Current Assets VS Current LiabilitesTSAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

3

3. TSAT Growth Analysis

3.1 Past

  • The earnings per share for TSAT have decreased strongly by -60.63% in the last year.
  • TSAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.81%.
  • The Revenue for TSAT have been decreasing by -12.62% on average. This is quite bad
EPS 1Y (TTM)-60.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.21%
Revenue 1Y (TTM)-26.81%
Revenue growth 3Y-18.04%
Revenue growth 5Y-12.62%
Sales Q2Q%-26.53%

3.2 Future

  • TSAT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.39% yearly.
  • The Revenue is expected to grow by 31.28% on average over the next years. This is a very strong growth
EPS Next Y-54.1%
EPS Next 2Y-4.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-17.1%
Revenue Next 2Y2.67%
Revenue Next 3Y29.36%
Revenue Next 5Y31.28%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TSAT Yearly Revenue VS EstimatesTSAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
TSAT Yearly EPS VS EstimatesTSAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

0

4. TSAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TSAT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSAT Price Earnings VS Forward Price EarningsTSAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • TSAT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. TSAT is more expensive than 70.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.79
TSAT Per share dataTSAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

  • A cheap valuation may be justified as TSAT's earnings are expected to decrease with -4.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.39%
EPS Next 3YN/A

0

5. TSAT Dividend Analysis

5.1 Amount

  • TSAT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TSAT Fundamentals: All Metrics, Ratios and Statistics

TELESAT CORP

NASDAQ:TSAT (3/25/2026, 8:01:21 PM)

After market: 40.38 0 (0%)

40.38

+1.04 (+2.64%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)03-17
Earnings (Next)05-04
Inst Owners55.74%
Inst Owner Change-0.5%
Ins Owners5.33%
Ins Owner Change0%
Market Cap2.06B
Revenue(TTM)417.96M
Net Income(TTM)-155.35M
Analysts43.33
Price Target27.72 (-31.35%)
Short Float %7.79%
Short Ratio6.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.08%
Min EPS beat(2)-149.66%
Max EPS beat(2)29.51%
EPS beat(4)3
Avg EPS beat(4)51.33%
Min EPS beat(4)-149.66%
Max EPS beat(4)185.61%
EPS beat(8)5
Avg EPS beat(8)-183.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.47%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)2.04%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.91%
PT rev (3m)-44.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.79
P/FCF N/A
P/OCF 42.52
P/B 5.34
P/tB N/A
EV/EBITDA 27.79
EPS(TTM)-6.38
EYN/A
EPS(NY)-9.83
Fwd EYN/A
FCF(TTM)-9.94
FCFYN/A
OCF(TTM)0.95
OCFY2.35%
SpS5.95
BVpS7.56
TBVpS-30.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.35%
ROE -29.27%
ROCE 1.74%
ROIC 1.38%
ROICexc 1.63%
ROICexgc 37.95%
OM 13.71%
PM (TTM) N/A
GM 94.56%
FCFM N/A
ROA(3y)-0.37%
ROA(5y)0.03%
ROE(3y)-5.96%
ROE(5y)0.43%
ROIC(3y)2.65%
ROIC(5y)3.11%
ROICexc(3y)3.3%
ROICexc(5y)4.01%
ROICexgc(3y)20.63%
ROICexgc(5y)18.82%
ROCE(3y)3.35%
ROCE(5y)3.93%
ROICexgc growth 3Y32.21%
ROICexgc growth 5Y10.24%
ROICexc growth 3Y-31.44%
ROICexc growth 5Y-25.2%
OM growth 3Y-29.46%
OM growth 5Y-22.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.29%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA 5.59
Cap/Depr 513.87%
Cap/Sales 183.06%
Interest Coverage 0.31
Cash Conversion 32.35%
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.01
F-Score4
WACC5.74%
ROIC/WACC0.24
Cap/Depr(3y)462.11%
Cap/Depr(5y)312.32%
Cap/Sales(3y)132.45%
Cap/Sales(5y)89.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.21%
EPS Next Y-54.1%
EPS Next 2Y-4.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.81%
Revenue growth 3Y-18.04%
Revenue growth 5Y-12.62%
Sales Q2Q%-26.53%
Revenue Next Year-17.1%
Revenue Next 2Y2.67%
Revenue Next 3Y29.36%
Revenue Next 5Y31.28%
EBIT growth 1Y-74.5%
EBIT growth 3Y-42.19%
EBIT growth 5Y-32.39%
EBIT Next Year317.44%
EBIT Next 3Y153.43%
EBIT Next 5Y103.26%
FCF growth 1Y33.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.79%
OCF growth 3Y-33.69%
OCF growth 5Y-29.1%

TELESAT CORP / TSAT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TELESAT CORP?

ChartMill assigns a fundamental rating of 2 / 10 to TSAT.


Can you provide the valuation status for TELESAT CORP?

ChartMill assigns a valuation rating of 0 / 10 to TELESAT CORP (TSAT). This can be considered as Overvalued.


Can you provide the profitability details for TELESAT CORP?

TELESAT CORP (TSAT) has a profitability rating of 3 / 10.


What is the financial health of TELESAT CORP (TSAT) stock?

The financial health rating of TELESAT CORP (TSAT) is 0 / 10.


What is the expected EPS growth for TELESAT CORP (TSAT) stock?

The Earnings per Share (EPS) of TELESAT CORP (TSAT) is expected to decline by -54.1% in the next year.